Devyce, a London, UK-based SaaS company that provides digital phone numbers to multinational businesses, closed a $2.7 million (£2.2m) seed funding round. The round was led by Y Combinator, with participation from Garage Capital, FoundersX Ventures, and individual investors John Kim, founder & CEO of Sendbird, and Ryan Chan, founder …

Henchman, a Ghent, Belgium-based legal tech company, announced that it closed a $7 million Series A funding, bringing its total raised to $10 million, to become the industry-leading contract drafting and negotiation solution. The round was led by Adjacent VC and Acton Capital, with participation from several business angels, including …

Doctorly, a Berlin, Germany-based medical practice management software startup, raised $10 million in Series A funding. The investment was from investors WELL Health Technologies and Horizons Ventures. Other investors in the round include The Delta, Speedinvest, UNIQA Ventures, Calm/Storm Ventures, and Seedcamp. The startup's goal is to scale in its …

Desana, an Edinburgh, Scotland-based B2B hybrid workspace platform that enables companies to give their employees much more flexibility, closed $7.4 million in funding. The round was co-led by PT1—PropTech1 Ventures and JLL Spark, with participation from Desana pre-seed investor Techstart Ventures, BGF, and Groundbreak Ventures. The new funding is intended …

Hectare, an England, UK-based agritech company that provides inventory, trading, market insights, and logistics solutions, raised $20 million in Series A funding to accelerate the growth of its digital solutions that connect the critical parts of the food supply chain. The round was led by existing and private investors. The …

Humanising Autonomy, a London, UK-based company building the global standard for human-machine interactions, announced that it raised debt funding. The investment was from Silicon Valley Bank UK, a financial partner shaping the innovation economy. The funds will be used to support the company's expansion into new markets as well as …

Antiverse, a Wales, UK-based biotechnology company developing a computational antibody drug discovery platform, announced that it raised $3 million in funding. The company also announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity. The investment was from new …